Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: J Allergy Clin Immunol. 2019 Nov 6;145(1):38–45. doi: 10.1016/j.jaci.2019.10.027

FIGURE 1:

FIGURE 1:

Development pipeline of EoE-specific programs over the last two decades with progression from phase I/II to phase III stage. EG, eosinophilic gastritis.